Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in Prisons.
Aaron Guanliang LimJack StoneBehzad HajarizadehMarianne ByrneGeorgina M ChambersNatasha K MartinJason GrebelyGregory J DoreAndrew R LloydPeter VickermanPublished in: Hepatology (Baltimore, Md.) (2021)
Our results demonstrate the prevention benefits of scaling up HCV treatment in prison settings. Prison-based DAA scale-up should be an important component of HCV elimination strategies.